高级搜索

VEGF抑制剂的抗肿瘤相关常见不良反应及其干预策略

VEGF Inhibitor-Associated Class-Effect Toxicities in Antitumor Therapy: Mechanistic Insights and Clinical Mitigation Strategies

  • 摘要: 血管内皮生长因子(Vascular Endothelial Growth Factor, VEGF)抑制剂是一种靶向抑制肿瘤血管生成的药物,通过阻断VEGF及其受体的信号通路抑制肿瘤增殖,在肿瘤治疗中发挥了重要作用。然而,其治疗过程中的相关毒副反应(如高血压、手足皮肤反应、骨髓抑制)严重影响患者治疗依从性和生存质量,甚至导致治疗中断。因此探索VEGF抑制剂不良反应的干预策略对肿瘤治疗具有重要意义。本文就VEGF抑制剂在肿瘤治疗过程中产生的高血压、手足皮肤反应和骨髓抑制等常见不良反应的临床特征、毒性机制等展开综述,并总结了针对性的中西医结合的干预策略。精准监测、调整药物剂量以达到抗肿瘤的目的,采用益气活血、健脾补肾等中药针对性地改善患者不适症状,中西药协同救治患者,为肿瘤患者提供更安全有效的治疗方案。

     

    Abstract: Vascular endothelial growth factor (VEGF) inhibitors are drugs that target and inhibit tumor angiogenesis. By blocking the VEGF/VEGFR signaling pathway, they suppress tumor proliferation and play a significant role in tumor treatment. However, the related toxic and side effects during its treatment process (such as hypertension, hand-foot skin reactions, and bone marrow suppression) seriously affect patients' treatment compliance and quality of life. Exploring intervention strategies for adverse reactions of VEGF inhibitors is of great significance for tumor treatment. This article reviews the clinical characteristics and toxic mechanisms of common adverse reactions such as hypertension, hand-foot skin reactions, and bone marrow suppression caused by VEGF inhibitors during tumor treatment, and summarizes targeted intervention strategies combining traditional Chinese and Western medicine. Precise monitoring and adjustment of drug dosages are carried out to achieve the goal of anti-tumor treatment. Targeted improvement of patients' discomfort symptoms is achieved through prescriptions such as tonifying qi and promoting blood circulation, strengthening the spleen and tonifying the kidney. The combination of traditional Chinese and Western medicines is used to treat patients, providing a safer and more effective treatment plan for cancer patients.

     

/

返回文章
返回